Abstract
We report herein the synthesis and biological activities (cytotoxicity, leishmanicidal and trypanocidal) of six quinoline-chalcone and five quinoline-chromone hybrids. The synthesized compounds were evaluated against amastigotes forms of Leishmania (V) panamensis, which is the most prevalent Leishmania species in Colombia and Trypanosoma cruzi, which is the major pathogenic species to humans. Cytotoxicity was evaluated against human U-937 macrophages. Compounds 8–12, 20, 23 and 24 showed activity against Leishmania (V) panamensis, while compounds 9, 10, 12, 20 and 23 had activity against Trypanosoma cruzi with EC50 values lower than 18 mg mL−1. 20 was the most active compound for both Leishmania (V) panamensis and Trypanosoma cruzi with EC50 of 6.11 ± 0.26 μg mL−1 (16.91 μM) and 4.09 ± 0.24 (11.32 μM), respectively. All hybrids compounds showed better activity than the anti-leishmanial drug meglumine antimoniate. Compounds 20 and 23 showed higher activity than benznidazole, the current anti-trypanosomal drug. Although these compounds showed toxicity for mammalian U-937 cells,they still have the potential to be considered as candidates to antileishmanial or trypanocydal drug development.
Similar content being viewed by others
References
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M (2012) Leishmaniasis worldwide and global estimates of its incidence. PLOS One 7:e35671
Baloch N, Alkahraman Y, Zaidi M, Madkour H (2012) Evaluation of 6, 8-dichloro-2-methyl-4H-chromen-4-one derivatives as Antileishmanial agents. Glob J Sci Front Res Chem 12:1–7
Bhutta ZA, Sommerfeld J, Lassi ZS, Salam RA, Das JK (2014) Tackling the existing burden of infection diseases in the developing world: existing gaps and the way forward. Infect Dis Poverty 3:1–6
Boeck P, Bandeira Falcão CA, Leal PC, Yones RA, Filho VC, Torres-Santos EC, Rossi-Bergmann B (2006) Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 14:1538–1545
Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40:2592–2597
Cardona W, Arango V, Domínguez J, Robledo S, Muñoz D, Figadère B, Velez ID, Sáez J (2013) Synthesis and leishmanicidal activity of new bis-alkylquinolines. J Chil Chem Soc 58:1709–1712
Cardona W, Guerra D, Restrepo A (2014) Reactivity of δ-substituted α,β-unsaturated cyclic lactones with antileishmanial activity. Mol Simul 40:477–484
Chatelain E, Ioset JR (2011) Drug discovery and development for neglected diseases: the DNDi model. Drug Des Devel Ther 16:175–181
Chen M, Zhai L, Christensen SB, Theander TG, Kharazmi A (2001) Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrobiol. Agents Chemother 45:2023–2029
Coa JC, Castrillón W, Cardona W, Carda M, Ospina V, Muñoz JA, Vélez ID, Robledo SM (2015) Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids. Eur J Med Chem 101:746–753
Den Boer M, Argaw D, Jannin J, Alvar J (2011) Leishmaniasis impact and treatment access. Clin Microbiol Infect 17:1471–1477
Dietze R, Carvalho SF, Valli LC, Berman J, Brewer T, Milhous W, Sanchez J, Schuster B, Grogl M (2001) Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. Am J Trop Med Hyg 65:685–689
Ellis GP, Barker G (1972) Chromone-2- and -3-carboxylic acids and their derivatives. Prog Med Chem 9:65–116
Finney JD (1978) Probit analysis: statistical treatment of the sigmoid response curve, 3rd ed.. Cambridge University Press, Cambridge, p 550
Franck X, Fournet A, Prina E, Mahieux R, Hocquemiller R, Figadère B (2004) Biological evaluation of substituted quinolones. Bioorg Med Chem Lett 14:3635–3638
Hadjeri M, Barbier M, Ronot X, Mariotte AM, Boumendjel A, Boutonnat J (2003) Modulation of P- glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues. J Med Chem 46:2125–2131
Horton DA, Boume GT, Smythe ML (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 103:893–930
Houghton PJ (2000) Chemistry and biological activity of natura land semi-synthetic 450 chromone alkaloids. Stud Nat Prod Chem 21:123–155
Insuasty B, Ramirez J, Becerra D, Echeverry C, Quiroga J, Abonia R, Robledo SM, Velez ID, Upegui Y, Muñoz JA, Ospina V, Nogueras M, Cobo J (2015) An efficient synthesis of a new caffeine-based chalcones, pyrazolines and pyrazolo[3-4-b][1-4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents. Eur J Chem Med 93:401–413
Kayser O, Kiderlen AF (2001) In vitro leishmanicidal activity of naturally occurring chalcones. Phytother Res 15:148–152
Keenan M, Chaplin JH (2015) A new era for chagas disease drug discovery? Prog Med Chem 54:185–230
Li SY, Wang XB, Xie SS, Jian N, Wang KD, Yao HQ, Sun HB, Kong LY (2013) Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease. Eur J Med Chem 69:632–646
Liu M, Wilairat P, Croft SL, Tand AL, Go ML (2003) Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg Med Chem 11:2729–2738
Mallick S, Dutta A, Ghosh J, Maiti S, Mandal AK, Banerjee R, Bandyopadhyay C, Pal C (2011) Protective therapy with novel chromone derivative against Leishmania donovani infection induces Th1 response in vivo. Chemotherapy 57:388–393
Mohammed AF, Fournet A, Prina E, Mouscadet JF, Franck X, Hocquemiller R, Figadère B, Fakhfakh MA (2003) Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11:5013–5023
Mottram JC, Coombs GH, Alexander J (2004) Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 7:375–381
Nakayama H, Loiseau PM, Bories C, De Ortiz ST, Schinini A, Serna E, Rojas de Arias A, Fakhfakh MA, Franck X, Figadère B, Hocquemiller R, Fournet A (2005) Efficacy of orally administered 2- substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 49:4950–4956
Nouvellet P, Cucunubá ZM, Gourbière S (2015) Ecology, evolution and control of Chagas disease: a century of neglected modelling and promising future. Adv Parasitol 87:135–191
Otero E, Vergara S, Robledo SM, Cardona W, Carda M, Vélez ID, Rojas C, Otálvaro F (2014) Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids. Molecules 19:13251–13266
Palit P, Paira P, Hazra A, Banerjee S, Das Gupta A, Dastidar S, Mondal N (2009) Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation. Eur J Med Chem 44:845–853
Peng Y, Song G (2002) Combined microwave and ultrasound assisted Williamson ether synthesis in the absence of phase-transfer catalysts. Green Chem 4:349–351
Peyman S, Minoo D, Mohammad AZ, Mohammad AB (2004) Silica sulfuric acid as an efficient and reusable reagent for crossed-aldol condensation of ketones with aromatic aldehydes under solvent-free conditions. J Braz Chem Soc 15:773–776
Pulido SA, Muñoz DL, Restrepo AM, Mesa CV, Alzate JF, Vélez ID, Robledo SM (2012) Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Acta Trop 122:36–45
Suresh K, Sandhya B, Himanshu G (2009) Biological activities of quinoline derivatives. Mini Rev Med Chem 9:1648–1654
Taylor VM, Cedeño DL, Muñoz DL, Jones MA, Lash TD, Young AM, Constantino MH, Esposito N, Vélez ID, Robledo SM (2011) In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 55:4755–4764
Tempone A, Melo A, Da Silva P, Brandt C, Martinez F, Borborema A (2005) Synthesis and antileishmanial activities of novel 3-substituted quinolones. Agents chemother 49:1076–1080
Vieira NC, Herrenknecht C, Vacus J, Fournet A, Bories C, Figadère B, Espindola LS, Loiseau PM (2008) Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. Biomed Pharmacother 62:684–689
World Health Organization (2013) Why are some tropical diseases called ‘neglected’ http://www.who.int/features/qa/58/en/. Accessed 4 Dec 2013
Acknowledgements
The authors thank Universidad de Antioquia (grant CODI IN656CE and CIDEPRO) for financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Coa, J.C., García, E., Carda, M. et al. Synthesis, leishmanicidal, trypanocidal and cytotoxic activities of quinoline-chalcone and quinoline-chromone hybrids. Med Chem Res 26, 1405–1414 (2017). https://doi.org/10.1007/s00044-017-1846-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1846-5